Incyte appoints Dr. Pablo J. Cagnoni as President, R&D, effective June 5, 2023

INCYTE CORP

Board approved appointment of Pablo J. Cagnoni, M.D. as President, Research and Development on May 4, 2023.
Appointment becomes effective June 5, 2023.
No other executive changes or succession details disclosed in filing.

item 8.01

INCYTE CORP filing history →

Source: SEC EDGAR

accession 0001104659-23-057267

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.